Arbovirus Testing Market: Public Health Laboratories have been carrying out Arbovirus Testing on a large scale across the Globe


Arbovirus (Arthropod Borne Virus) is used to describe infection caused by viruses that spread to people through infected arthropods like mosquitoes, ticks and others.  E.g. West Nile Fever, Zika, Dengue, Chikungunya, Eastern Equine Encephalitis, Western Equine Encephalitis, Powassan, and others. Over 200 viruses are known to cause infection in humans and they are classified into three classes. Togaviridae – E.g. Yellow fever, West Nile virus, Zika virus, Dengue fever, Japanese encephalitis and others. Flaviviridae – E.g. Ross River virus, Eastern equine virus, Western equine virus, Chikungunya and others. Bunyaviridae- E.g. California encephalitis, La Crosse virus, Jamestown Canyon virus and others

Global Arbovirus testing market revenue is expected to increase at a CAGR of 5.6% during the forecast period (2017–2025). In terms of revenue, ELISA-based Tests segment was the dominant Test Type segment in the global Arbovirus Testing Market in 2016. The segment is expected to further gain traction, owing to its high penetration. RT-PCR based tests segment was expected to register the fastest CAGR of 6.0% during forecast period and is expected to gain significant market share by 2025 end, owing to increasing focus of manufactures on PCR. Asia-Pacific Arbovirus Testing Market accounted for largest revenue market share of 26.9% in 2017. Revenue from the market in Asia-Pacific is expected to register the CAGR of 6.2% during the forecast period.

Emerging Arboviruses – Arbovirus infections are emerging at high pace and one of the major cause of neurological diseases throughout North America. In most of the Arbovirus cases, there is no US FDA approved therapies. In most of the cases, prompt recognition and diagnosis ensure appropriate cure for the patient. According to CDC USA, 5,575 symptomatic Zika virus disease cases reported in USA states from 2015 to 2017.  37,075 symptomatic Zika virus disease cases reported in US territories from 2015 to 2017. In Zika Virus, there is no vaccine or specific treatment. Early diagnosis is only possible way to treat Zika virus effectively which boost the testing market.

Re-emergence of Arbovirus- Disordered urban growth, environmental changes due to changing lifestyle, and globalization are major causes of dissemination and emergence of arbovirus infections. Arbovirus pose a significant threat to public health due to re-emergence of infection cause widespread epidemics of human and animal diseases and make them more unpredictable All these leads to sporadic outbreaks in Latin America. E.g. Brazilian national authorities estimate that between 497,593 and 1,482,701 cases of Zika virus infection have occurred since the outbreak began. After Brazil, Colombia has been the most-affected country so far, with 20,297 cases reported (Jan 2016) since the country’s first cases were detected in October 2015.

Asia Pacific represents the most lucrative market, followed by Middle East & Africa and Latin America regions. Asia Pacific Arbovirus Testing Market is witnessed a robust growth due to the presence of huge population of this region are at high risk of arbovirus infections. Other key factors driving the growth of the Arbovirus Testing s market in this region is the high incidence among the all age groups expected to boost demand for Arbovirus Testing drugs over the forecast period.

Some of the key players in the global Arbovirus Testing Market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Molecular Systems Inc., Euroimmun AG (Sub. PerkinElmer), Quest Diagnostics, NovaTec Immundiagnostica GmbH, InBios International, Inc., Certest Biotec S.L. and Others.

Request to View Sample of Research Report @

Leave a Reply